1981.00GBp-0.10%Mkt Cap: 86.27B $P/E: 13.951d ago
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Cheaper
P/B
Avg
Div Yield
Lower
1M Perf
Avg
$1.07TUSDP/E 42.6
$611.36BUSDP/E 29.4
$444.21BUSDP/E 123.9
$308.01BUSDP/E 21.1
$317.37BUSDP/E 36.2
$281.52BUSDP/E 22.5
$275.65BUSDP/E 22.4
$269.91BUSDP/E 28.1
$237.69BUSDP/E 28.0
$202.85BUSDP/E 11.5
$195.44BUSDP/E 25.2
$156.86BUSDP/E 17.2
$137.24BUSDP/E 18.4
$117.66BUSDP/E 16.1
$97.68BUSDP/E 19.0
$51.69BUSD
$31.90BUSDP/E 23.3
MRV
Marvell Technology, Inc.$30.93BUSDP/E 11.7
$11.35BUSDP/E 22.7
$11.02BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.60BUSDP/E 14.6
$3.56BUSDP/E 14.6
$3.03BUSDP/E 18.5
$54.86MUSD
$39.77MUSD
ELXR
Elixxer Ltd.$9.51MUSD
PHOO
Photocure ASA—
ROSE
DocMorris AG—
FLXN
Horizon Flexible Income ETF—P/E 27.2
CELG-RI
Bristol-Myers Squibb Company Ce—
Indicators:|
Key Statistics
Company
Market Cap86.27B $
Enterprise Value103.13B $
Revenue (TTM)35.63B $
Gross Profit25.71B $
Net Income (TTM)6.21B $
Revenue/Share8.830 USD
Last Price1981.00 GBp
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees66.8K
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)13.95
P/E (Forward)10.26
PEG19.76
EV/EBITDA8.30
EV/Revenue2.89
P/S2.42
P/B4.46
EPS (TTM)1.42
EPS (Forward)1.93
52W Range
1288.6070% of range2282.00
52W High2282.00 GBp
52W Low1288.60 GBp
Profitability
Gross Margin72.40%
Oper. Margin36.28%
EBITDA Margin34.88%
Profit Margin17.50%
ROE34.90%
ROA9.35%
Growth
Revenue Growth1.50%
Earnings Growth8.40%
Cash Flow & Leverage
Operating CF8.41B $
CapEx (TTM)3.24B $
FCF Margin9.21%
FCF Yield3.80%
Net Debt17.03B $
Net Debt/EBITDA1.37
Balance Sheet
Debt/Equity1.08
Current Ratio0.79
Quick Ratio0.51
Book Value/Sh4.441 GBp
Cash/Share0.8560 GBp
Dividends
Fwd Div Rate0.6800 GBp
Trail. Div Rate0.6700 GBp
Div. Yield3.44%
5Y Avg Yield4.37%
Payout Ratio46.45%
Ex-Div DateMay 14, 2026
Pay Date—
Splits
Last Split4:5
Split DateJul 19, 2022
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2092.16 GBp
Upside (mean)+5.6%
Target Range1455.00 GBp – 2825.00 GBp
GBp1455.00+5.6% to meanGBp2825.00
# Analysts19
Ownership
Shares Out.4.01B
Float3.89B
Insiders1.75%
Institutions47.32%
Technical
SMA 501927.64 (+2.8%)
SMA 2001896.87 (+4.4%)
Beta0.29
S&P 52W Chg20.05%
Avg Vol (30d)6.75M
Avg Vol (10d)8.45M
Technical Indicators
RSI (14)57.5
MACD12.4631
MACD Signal5.6337
MACD Hist.+6.8294
BB Upper2022.31 GBp
BB Middle1935.25 GBp
BB Lower1848.19 GBp
BB Width9.00%
ATR (14)50.05 GBp
Vol Ratio (20d)2.13x